Who Supplies Fludarabine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Fludarabine exports, with 64+ registered manufacturers shipping to buyers across 49+ countries — yet a handful of companies dominate the shipments. INTAS PHARMACEUTICALS LIMITED holds the largest share at 29.0% (export value: $837.9K). Close behind, AXA PARENTERALS LIMITED (9.0%, $259.5K). UNITED BIOTECH PRIVATE LIMITED (3.6%, $104.3K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Fludarabine? Top Manufacturers & Their Buyers
Flow of Fludarabine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Fludarabine Supplier Network — Key Market Intelligence
The Fludarabine export market from India is led by INTAS PHARMACEUTICALS LIMITED, which alone commands a 29.0% share, shipping $837.9K worth of product across 167 shipments. The second-largest exporter, AXA PARENTERALS LIMITED, contributes $259.5K (9.0%) to the overall market. Combined, the top two suppliers alone account for 38.0% of all Fludarabine exports, indicating a relatively concentrated supply base.
Across all 64 tracked manufacturers, the total Fludarabine export value stands at $2.9M from 387 shipments. The market average shipment value is $7.5K. The single largest buyer relationship in terms of trade value is ACCORD HEALTHCARE POLSKA SP Z O O, receiving $164.8K worth of product.
The combined buyer network spans 13 named purchasing companies, including ACCORD HEALTHCARE POLSKA SP Z O O, BROCACEF NL : HUB, ACCORD UK, ALLOGA FRANCE, BANQUE NATIONALE D and 8 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the first-largest Fludarabine exporter from India, with a market share of 29.0% and a total export value of $837.9K across 167 shipments. Their average shipment value of $5.0K is below the market average of $7.5K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER — $313.4K across 62 shipments (37.4% of this supplier's total exports)
• ACCORD HEALTHCARE POLSKA SP Z O O — $164.8K across 33 shipments (19.7% of this supplier's total exports)
• BROCACEF NL : HUB — $161.5K across 32 shipments (19.3% of this supplier's total exports)
• ACCORD UK — $101.5K across 20 shipments (12.1% of this supplier's total exports)
• ALLOGA FRANCE — $96.8K across 19 shipments (11.6% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (167 shipments) at a per-shipment value of $5.0K, indicating a broad distribution network with many smaller, regular orders.
2AXA PARENTERALS LIMITED
AXA PARENTERALS LIMITED is the second-largest Fludarabine exporter from India, with a market share of 9.0% and a total export value of $259.5K across 5 shipments. Their average shipment value of $51.9K is above the market average of $7.5K, suggesting premium or bulk contract pricing.
AXA PARENTERALS LIMITED serves 1 named buyer in our database. TO THE ORDER OF PURC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF PURC — $259.5K across 5 shipments (100.0% of this supplier's total exports)
Key Insight: AXA PARENTERALS LIMITED's per-shipment value of $51.9K is 596% above the market average of $7.5K, consistent with large-order contracts or value-added formulations.
3UNITED BIOTECH PRIVATE LIMITED
UNITED BIOTECH PRIVATE LIMITED is the third-largest Fludarabine exporter from India, with a market share of 3.6% and a total export value of $104.3K across 25 shipments. Their average shipment value of $4.2K is below the market average of $7.5K, reflecting a high-volume, competitive pricing strategy.
UNITED BIOTECH PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• BANQUE NATIONALE D — $50.3K across 12 shipments (48.2% of this supplier's total exports)
• BANQUE NATIONALE DAL — $18.8K across 4 shipments (18.0% of this supplier's total exports)
• AFRIKA TRADE & REPRE — $18.1K across 4 shipments (17.3% of this supplier's total exports)
• OZMEDIMPECKS LLC — $12.4K across 3 shipments (11.8% of this supplier's total exports)
• SONERI BANK — $4.8K across 1 shipments (4.6% of this supplier's total exports)
Key Insight: UNITED BIOTECH PRIVATE LIMITED operates with high shipment frequency (25 shipments) at a per-shipment value of $4.2K, indicating a broad distribution network with many smaller, regular orders.
4LIFEON PHARMACEUTICALS
LIFEON PHARMACEUTICALS is the fourth-largest Fludarabine exporter from India, with a market share of 1.1% and a total export value of $33.0K across 7 shipments. Their average shipment value of $4.7K is below the market average of $7.5K, reflecting a high-volume, competitive pricing strategy.
LIFEON PHARMACEUTICALS serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MUNIC LITHUANIA LITH — $15.6K across 3 shipments (47.3% of this supplier's total exports)
• TO THE ORDER OF — $10.6K across 2 shipments (32.2% of this supplier's total exports)
• TO THE ORDER OF — $6.8K across 1 shipments (20.5% of this supplier's total exports)
Key Insight: LIFEON PHARMACEUTICALS operates with high shipment frequency (7 shipments) at a per-shipment value of $4.7K, indicating a broad distribution network with many smaller, regular orders.
5ATLAS ENTERPRISES
ATLAS ENTERPRISES is the fifth-largest Fludarabine exporter from India, with a market share of 1.1% and a total export value of $32.2K across 11 shipments. Their average shipment value of $2.9K is below the market average of $7.5K, reflecting a high-volume, competitive pricing strategy.
ATLAS ENTERPRISES serves 1 named buyer in our database. MR HARJEET SINGH HEA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• MR HARJEET SINGH HEA — $32.2K across 11 shipments (100.0% of this supplier's total exports)
Key Insight: ATLAS ENTERPRISES operates with high shipment frequency (11 shipments) at a per-shipment value of $2.9K, indicating a broad distribution network with many smaller, regular orders.
6BETA DRUGS LIMITED
BETA DRUGS LIMITED is the fifth-largest Fludarabine exporter from India, with a market share of 0.5% and a total export value of $15.3K across 6 shipments. Their average shipment value of $2.6K is below the market average of $7.5K, reflecting a high-volume, competitive pricing strategy.
BETA DRUGS LIMITED serves 2 named buyers in our database. ALSHAMELAH FOR TRADI is the dominant customer, accounting for 72.7% of this supplier's tracked business. Top customers include:
• ALSHAMELAH FOR TRADI — $11.2K across 4 shipments (72.7% of this supplier's total exports)
• GLOBAL CARE PHARMACA — $4.2K across 2 shipments (27.3% of this supplier's total exports)
Key Insight: BETA DRUGS LIMITED operates with high shipment frequency (6 shipments) at a per-shipment value of $2.6K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Fludarabine Flows
Once Fludarabine leaves the manufacturing plants of companies like INTAS PHARMACEUTICALS LIMITED and AXA PARENTERALS LIMITED, it travels to 5 destination markets with a combined import value of $2.9M. Poland absorbs the largest share at 18.0% ($519.1K), followed by Netherlands (16.0%) and Venezuela (14.9%).
In Poland — the top destination — named importers include ACCORD HEALTHCARE POLSKA SP. Z O.O., ACCORD HEALTHCARE POLSKA SP.Z.O.O., ACCORD HEALTHCARE POLSKA SP Z O O. In Netherlands, key buyers are BROCACEF NL : HUB, BROCACEF NL HUB, BROCACEF NL:HUB BROCACEF HEALTHCAR.
This geographic spread reflects Fludarabine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Fludarabine Go? Top Importing Countries & Their Buyers
Trade flow of Fludarabine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Poland
Poland ranks as the first-largest destination for Fludarabine imports from India, with a total trade value of $519.1K across 18 shipments — representing a 18.0% share of all Fludarabine exports. The average shipment value of $28.8K is above the global average of $7.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Fludarabine importers in Poland: ACCORD HEALTHCARE POLSKA SP. Z O.O. is the largest buyer, accounting for 45.0% ($233.4K) of this market's total imports.
• ACCORD HEALTHCARE POLSKA SP. Z O.O. — $233.4K (45.0% of Poland's total)
• ACCORD HEALTHCARE POLSKA SP.Z.O.O. — $148.5K (28.6% of Poland's total)
• ACCORD HEALTHCARE POLSKA SP Z O O — $90.3K (17.4% of Poland's total)
Key Insight: Poland's per-shipment average of $28.8K (287% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Poland is a key market for Fludarabine imports from India.
2Netherlands
Netherlands ranks as the second-largest destination for Fludarabine imports from India, with a total trade value of $462.2K across 22 shipments — representing a 16.0% share of all Fludarabine exports. The average shipment value of $21.0K is above the global average of $7.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Fludarabine importers in Netherlands: BROCACEF NL : HUB is the largest buyer, accounting for 45.7% ($211.4K) of this market's total imports.
• BROCACEF NL : HUB — $211.4K (45.7% of Netherlands's total)
• BROCACEF NL HUB — $71.3K (15.4% of Netherlands's total)
• BROCACEF NL:HUB BROCACEF HEALTHCAR — $64.2K (13.9% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $21.0K (182% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Fludarabine imports from India.
3Venezuela
Venezuela ranks as the third-largest destination for Fludarabine imports from India, with a total trade value of $431.0K across 2 shipments — representing a 14.9% share of all Fludarabine exports. The average shipment value of $215.5K is above the global average of $7.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Fludarabine importers in Venezuela: SERVICIOS MEDIPLUS C.A. is the largest buyer, accounting for 33.7% ($145.0K) of this market's total imports.
• SERVICIOS MEDIPLUS C.A. — $145.0K (33.7% of Venezuela's total)
Key Insight: Venezuela's per-shipment average of $215.5K (2788% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Venezuela is a key market for Fludarabine imports from India.
4France
France ranks as the fourth-largest destination for Fludarabine imports from India, with a total trade value of $287.4K across 6 shipments — representing a 10.0% share of all Fludarabine exports. The average shipment value of $47.9K is above the global average of $7.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Fludarabine importers in France: ALLOGA FRANCE is the largest buyer, accounting for 54.7% ($157.2K) of this market's total imports.
• ALLOGA FRANCE — $157.2K (54.7% of France's total)
Key Insight: France's per-shipment average of $47.9K (542% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Fludarabine imports from India.
5Canada
Canada ranks as the fifth-largest destination for Fludarabine imports from India, with a total trade value of $199.8K across 2 shipments — representing a 6.9% share of all Fludarabine exports. The average shipment value of $99.9K is above the global average of $7.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Fludarabine importers in Canada: ACCORD HEALTHCARE INC., is the largest buyer, accounting for 90.9% ($181.7K) of this market's total imports.
• ACCORD HEALTHCARE INC., — $181.7K (90.9% of Canada's total)
Key Insight: Canada's per-shipment average of $99.9K (1239% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Fludarabine imports from India.
People Also Ask — Fludarabine Supplier & Trade Network
Who are the top suppliers of Fludarabine from India?+
Which companies buy Fludarabine from Indian manufacturers?+
Where does Fludarabine exported from India go?+
What is the market share of the top Fludarabine supplier from India?+
What is the average shipment value for Fludarabine exports from India?+
Is Fludarabine manufactured in India and exported globally?+
Which country imports the most Fludarabine from India?+
Who are the buyers of Fludarabine in Netherlands?+
How concentrated is the Fludarabine supplier market in India?+
How do I find verified buyers for Fludarabine in specific countries?+
Fludarabine Trade Network — Key Takeaways
- 1INTAS PHARMACEUTICALS LIMITED is India's dominant Fludarabine exporter with a 29.0% market share and $837.9K in total exports — making it the single most important sourcing entity in this market.
- 2The top 64 suppliers collectively account for 44.4% of all tracked Fludarabine exports, with a combined trade value of $2.9M.
- 3Poland is the largest destination market, absorbing 18.0% of India's Fludarabine exports ($519.1K). Netherlands (16.0%) and Venezuela (14.9%) follow.
- 4With 387 total shipments averaging $7.5K each, the Fludarabine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include ACCORD HEALTHCARE POLSKA SP Z O O, BROCACEF NL : HUB, BANQUE NATIONALE D, BANQUE NATIONALE DAL — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 49 countries
Network value: $2.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fludarabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Fludarabine.
- 2.Flow Mapping: 64 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 387 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 49 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
387 Verified Shipments
64 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists